Literature DB >> 16770164

Behçet disease.

Paul A Yates1, Joseph B Michelson.   

Abstract

Mesh：

Year:  2006        PMID： 16770164     DOI： 10.1097/00004397-200604620-00017

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  7 in total

Review 1.  Behçet's disease: global epidemiology of an Old Silk Road disease.

Authors:  Hiroshi Keino; Annabelle A Okada
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

Review 2.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.

Authors:  H Keino; A A Okada; T Watanabe; W Taki
Journal:  Eye (Lond)       Date:  2014-06-20       Impact factor: 3.775

Review 4.  [Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment].

Authors:  Nicole Stübiger; Sanaz Farrokhi; Yannik Gkanatsas; Christoph Deuter; Ina Kötter
Journal:  Z Rheumatol       Date:  2022-08-30       Impact factor: 1.530

5.  Clinical characteristics of Behçet's disease in China.

Authors:  Liao-Yuan Wang; Dong-Bao Zhao; Jun Gu; Sheng-Ming Dai
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

6.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet's syndrome.

Authors:  Noe Horiguchi; Koju Kamoi; Shintaro Horie; Yuko Iwasaki; Hisako Kurozumi-Karube; Hiroshi Takase; Kyoko Ohno-Matsui
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.